BBIO Return on Tangible Equity | BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BBIO) Return on Tangible Equity

2026-06-30: Return Tang Equity 27.62%.
2026-03-31: Return Tang Equity 31.66%.
2025-12-31: Return Tang Equity 34.66%.
2025-09-30: Return Tang Equity 41.07%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	27.62%
2026-03-31	31.66%
2025-12-31	34.66%
2025-09-30	41.07%
2025-06-30	43.19%
2025-03-31	40.38%
2024-12-31	36.42%
2024-09-30	35.58%
2024-06-30	41.28%
2024-03-31	50.84%
2023-12-31	47.32%
2023-09-30	50.51%
2023-06-30	42.04%
2023-03-31	33.98%
2022-12-31	37.77%
2022-09-30	42.51%
2022-06-30	49.00%
2022-03-31	57.56%
2021-12-31	64.07%
2021-09-30	72.09%
2021-06-30	115.95%
2021-03-31	144.83%
2020-12-31	-872.95%
2020-09-30	-277.62%
2020-06-30	-144.91%
2020-03-31	-84.90%
2019-12-31	-70.65%
2019-09-30	-55.18%
2019-06-30	-144.29%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	34.66%
2024-12-31	36.42%
2023-12-31	47.32%
2022-12-31	37.77%
2021-12-31	64.07%
2020-12-31	-872.95%
2019-12-31	-70.65%
2018-12-31	-53.81%
2017-12-31	-51.06%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52